Douglas Clark Wurth

CIK: 0001830551

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BJDX

Bluejay Diagnostics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

BJDX
Bluejay Diagnostics, Inc.
Aug 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
BJDX
Bluejay Diagnostics, Inc.
Mar 14, 2026
Purchase(P)
Direct
12.5K shares at avg. $2.00$25K

		Type	Shares	Price		Ownership
Aug 17, 2026	BJDX Bluejay Diagnostics, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Mar 14, 2026	BJDX Bluejay Diagnostics, Inc.	Purchase(P)	12,500	$2.00	$25,000	Direct

1-2 of 2 transactions

About Wurth Douglas Clark

Wurth Douglas Clark (SEC CIK 0001830551) files insider reports with the SEC as Director of Bluejay Diagnostics, Inc. (BJDX).

Signal8 holds 2 ownership filings by Wurth Douglas Clark, all Form 4s, filed between May 18, 2026 and Aug 18, 2026. Those filings report 2 transactions, from Mar 14, 2026 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wurth Douglas Clark's filings is in ACTON, MA.

Recent filings by Wurth Douglas Clark

Aug 17, 2026: Grant or award of BJDX derivative securities (Form 4, code A).
Mar 14, 2026: Open-market purchase of BJDX shares (Form 4, code P).

Other insiders filing for Bluejay Diagnostics, Inc. (BJDX)

ZEIDMAN FRED S, Director
Dey Svetlana, Director
Dey Indranil, President and CEO
CHASE DONALD R, Director
BANK OF AMERICA CORP /DE/, 10% Owner
HRT FINANCIAL LP, 10% Owner

How to read Form 4 transaction codes